Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1)
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04710-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Vassilios Aslanis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Galecto Biotech AB, Ole Maaløes Vej 3, DK-2200, Copenhagen, Denmark. v.aslanis@gmail.com. Hauptthemen laut MEDLINE: Cross-Over Studies, Biological Availability, Tablets, Food-Drug Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Galecto Biotech AB.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Galecto Biotech AB, Ole Maaløes Vej 3, DK-2200, Copenhagen, Denmark. v.aslanis@gmail.com.
- QPS Netherlands BV, Groningen, The Netherlands.
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
- Galecto Biotech AB, Ole Maaløes Vej 3, DK-2200, Copenhagen, Denmark.
ORCID-Profile: Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack, Kimberly Herman, Susan Tantawi, Fredrik R Zetterberg
Förderung
- Galecto Biotech AB
Zitieren
APA
Aslanis, V., Abd-Elaziz, K., Slack, R. J., Brinch, A., Gravelle, L., Morley, W., Phung, Herman, K., Holyer, I., Poulsen, K. K., Dogterom, P., Tantawi, S., Zetterberg, F. R., Jacoby, B., Schambye, H., & Lindmark, B. (2024). Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1). Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04710-3
Vancouver
Aslanis V, Abd-Elaziz K, Slack RJ, Brinch A, Gravelle L, Morley W, et al. Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1). Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04710-3
BibTeX
@article{Aslanis2024,
author = {Aslanis, Vassilios and Abd-Elaziz, Khalid and Slack, Robert J and Brinch, Anne and Gravelle, Lise and Morley, Wayne and Phung, De and Herman, Kimberly and Holyer, Ian and Poulsen, Karen Killerup and Dogterom, Peter and Tantawi, Susan and Zetterberg, Fredrik R and Jacoby, Brian and Schambye, Hans and Lindmark, Bertil},
title = {Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1)},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04710-3}
}
EUVIMED